• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液科患者群体中耐多药铜绿假单胞菌医院定植的临床及治疗相关危险因素:一项配对病例对照研究

Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study.

作者信息

Willmann Matthias, Klimek Anna M, Vogel Wichard, Liese Jan, Marschal Matthias, Autenrieth Ingo B, Peter Silke, Buhl Michael

机构信息

Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.

German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.

出版信息

BMC Infect Dis. 2014 Dec 10;14:650. doi: 10.1186/s12879-014-0650-9.

DOI:10.1186/s12879-014-0650-9
PMID:25490897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4266216/
Abstract

BACKGROUND

This study aimed to investigate risk factors for colonisation with extensively drug-resistant P. aeruginosa (XDR-PA) in immunocompromised patients and to build a clinical risk score (CRS) based on these results.

METHODS

We conducted a matched case-control study with 31 cases and 93 controls (1:3). Cases were colonised with XDR-PA during hospitalisation. Independent risk factors were determined using a three step conditional logistic regression procedure. A CRS was built with respect to the corresponding risk fraction of each risk factor, and its discriminatory power was estimated by receiver operating characteristic (ROC) analysis.

RESULTS

The presence of a central venous catheter (OR 7.41, P = 0.0008), the presence of a urinary catheter (OR 21.04, P < 0.0001), CRP > 10 mg/dl (OR 7.36, P = 0.0015), and ciprofloxacin administration (OR 5.53, P = 0.025) were independent risk factors. The CRS exhibited a high discriminatory power, defining a high risk population with an approximately fourteen times greater risk for XDR-PA colonisation.

CONCLUSIONS

Unnecessary use of antibiotics, particularly ciprofloxacin should be avoided, and a high standard of infection control measures must be achieved when using medical devices. A CRS can be used for adaptation of the active screening culture policy to the local setting.

摘要

背景

本研究旨在调查免疫功能低下患者中广泛耐药铜绿假单胞菌(XDR-PA)定植的危险因素,并基于这些结果构建临床风险评分(CRS)。

方法

我们进行了一项配对病例对照研究,病例31例,对照93例(1:3)。病例在住院期间被XDR-PA定植。使用三步条件逻辑回归程序确定独立危险因素。根据每个危险因素的相应风险分数构建CRS,并通过受试者工作特征(ROC)分析评估其鉴别能力。

结果

中心静脉导管的存在(比值比7.41,P = 0.0008)、导尿管的存在(比值比21.04,P < 0.0001)、CRP > 10 mg/dl(比值比7.36,P = 0.0015)以及环丙沙星给药(比值比5.53,P = 0.025)是独立危险因素。CRS显示出较高的鉴别能力,确定了XDR-PA定植风险约高14倍的高风险人群。

结论

应避免不必要地使用抗生素,尤其是环丙沙星,并且在使用医疗器械时必须达到高标准的感染控制措施。CRS可用于根据当地情况调整主动筛查培养策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d9a/4266216/e6799952a17d/12879_2014_Article_650_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d9a/4266216/e6799952a17d/12879_2014_Article_650_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d9a/4266216/e6799952a17d/12879_2014_Article_650_Fig1_HTML.jpg

相似文献

1
Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study.血液科患者群体中耐多药铜绿假单胞菌医院定植的临床及治疗相关危险因素:一项配对病例对照研究
BMC Infect Dis. 2014 Dec 10;14:650. doi: 10.1186/s12879-014-0650-9.
2
Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection.多重耐药铜绿假单胞菌医院感染的危险因素
J Hosp Infect. 2004 Jul;57(3):209-16. doi: 10.1016/j.jhin.2004.03.022.
3
Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.广泛和泛耐药铜绿假单胞菌角膜炎:临床特征、危险因素及预后
Graefes Arch Clin Exp Ophthalmol. 2016 Feb;254(2):315-22. doi: 10.1007/s00417-015-3208-7. Epub 2015 Nov 4.
4
Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.产金属β-内酰胺酶铜绿假单胞菌的医院感染:分子流行病学、危险因素、临床特征及转归
J Hosp Infect. 2014 Aug;87(4):234-40. doi: 10.1016/j.jhin.2014.05.007. Epub 2014 Jun 20.
5
Acute Inflammatory Response of Patients with Pseudomonas aeruginosa Infections: A Prospective Study.铜绿假单胞菌感染患者的急性炎症反应:一项前瞻性研究。
Microb Drug Resist. 2017 Jun;23(4):523-530. doi: 10.1089/mdr.2016.0144. Epub 2016 Oct 18.
6
Nosocomial outbreak of extensively drug-resistant Pseudomonas aeruginosa associated with aromatherapy.与芳香疗法相关的广泛耐药铜绿假单胞菌医院感染暴发
Am J Infect Control. 2017 Apr 1;45(4):453-455. doi: 10.1016/j.ajic.2016.11.002. Epub 2016 Nov 30.
7
Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.广泛耐药铜绿假单胞菌 235 型高危克隆引起的菌血症:直面完美风暴。
Int J Antimicrob Agents. 2018 Aug;52(2):172-179. doi: 10.1016/j.ijantimicag.2018.03.018. Epub 2018 Apr 3.
8
Risk factors for extreme-drug resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies.血液恶性肿瘤患者中极耐药铜绿假单胞菌感染的危险因素。
Am J Infect Control. 2013 Feb;41(2):140-4. doi: 10.1016/j.ajic.2012.02.025. Epub 2012 Jul 15.
9
Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review.广泛耐药铜绿假单胞菌定植和感染的流行情况及相关危险因素:系统评价。
Expert Rev Anti Infect Ther. 2015;13(9):1159-70. doi: 10.1586/14787210.2015.1064310. Epub 2015 Jul 7.
10
Nosocomial urinary tract infections caused by Pseudomonas aeruginosa and Acinetobacter species: sensitivity to antibiotics and risk factors.医院获得性铜绿假单胞菌和不动杆菌属引起的尿路感染:抗生素敏感性和危险因素。
Am J Infect Control. 2013 Dec;41(12):1182-7. doi: 10.1016/j.ajic.2013.02.018. Epub 2013 May 29.

引用本文的文献

1
population dynamics in a vancomycin-induced murine model of gastrointestinal carriage.万古霉素诱导的小鼠胃肠道携带模型中的种群动态
mBio. 2025 May 14;16(5):e0313624. doi: 10.1128/mbio.03136-24. Epub 2025 Apr 10.
2
population dynamics in a vancomycin-induced murine model of gastrointestinal carriage.万古霉素诱导的小鼠胃肠道携带模型中的种群动态
bioRxiv. 2024 Aug 20:2024.08.19.608679. doi: 10.1101/2024.08.19.608679.
3
Extensively drug-resistant : clinical features and treatment with ceftazidime/avibactam and ceftolozane/tazobactam in a tertiary care university hospital center in Portugal - A cross-sectional and retrospective observational study.

本文引用的文献

1
Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosa in critically ill patients.抗生素压力是重症患者直肠被多重耐药铜绿假单胞菌定植的主要危险因素。
Antimicrob Agents Chemother. 2014 Oct;58(10):5863-70. doi: 10.1128/AAC.03419-14. Epub 2014 Jul 21.
2
Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections.广泛耐药铜绿假单胞菌感染成年癌症患者的特征、风险因素和结局。
Infection. 2014 Aug;42(4):721-8. doi: 10.1007/s15010-014-0635-z. Epub 2014 Jun 10.
3
Value of American Thoracic Society guidelines in predicting infection or colonization with multidrug-resistant organisms in critically ill patients.
广泛耐药:葡萄牙一家三级医疗大学医院中心的临床特征及使用头孢他啶/阿维巴坦和头孢洛扎/他唑巴坦治疗——一项横断面回顾性观察研究
Front Microbiol. 2024 Feb 13;15:1347521. doi: 10.3389/fmicb.2024.1347521. eCollection 2024.
4
Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant and Extended-Spectrum β-Lactamase-Producing .广泛耐药菌与产超广谱β-内酰胺酶菌所致复杂性尿路感染的比较分析
Antibiotics (Basel). 2022 Oct 29;11(11):1511. doi: 10.3390/antibiotics11111511.
5
Infections in Cancer Patients.癌症患者的感染
Pathogens. 2022 Jun 12;11(6):679. doi: 10.3390/pathogens11060679.
6
XDR- Outside the ICU: Is There Still Place for Colistin?广泛耐药菌——重症监护病房之外:黏菌素是否仍有一席之地?
Antibiotics (Basel). 2022 Feb 1;11(2):193. doi: 10.3390/antibiotics11020193.
7
Transcriptomic Basis of Serum Resistance and Virulence Related Traits in XDR Evolved Under Antibiotic Pressure in a Morbidostat Device.在动态培养装置中抗生素压力下进化的耐多药菌株血清抗性和毒力相关性状的转录组学基础
Front Microbiol. 2021 Jan 25;11:619542. doi: 10.3389/fmicb.2020.619542. eCollection 2020.
8
Deprivation of the Periplasmic Chaperone SurA Reduces Virulence and Restores Antibiotic Susceptibility of Multidrug-Resistant .周质伴侣蛋白SurA的缺失降低了多药耐药菌的毒力并恢复了其对抗生素的敏感性
Front Microbiol. 2019 Feb 21;10:100. doi: 10.3389/fmicb.2019.00100. eCollection 2019.
9
Risk factors for hospitalized patients with resistant or multidrug-resistant infections: a systematic review and meta-analysis.住院患者耐多药或多重耐药感染的危险因素:系统评价和荟萃分析。
Antimicrob Resist Infect Control. 2018 Jul 4;7:79. doi: 10.1186/s13756-018-0370-9. eCollection 2018.
10
How to manage infections.如何控制感染。
Drugs Context. 2018 May 29;7:212527. doi: 10.7573/dic.212527. eCollection 2018.
美国胸科学会指南在预测危重症患者中耐多药生物体感染或定植的价值。
PLoS One. 2014 Mar 19;9(3):e89687. doi: 10.1371/journal.pone.0089687. eCollection 2014.
4
A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.一项系统评价和荟萃分析表明,碳青霉烯类药物的使用和医疗器械是耐碳青霉烯类铜绿假单胞菌的主要危险因素。
Antimicrob Agents Chemother. 2014 May;58(5):2626-37. doi: 10.1128/AAC.01758-13. Epub 2014 Feb 18.
5
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients.ESCMID 指南:管理感染控制措施以减少住院患者中多重耐药革兰氏阴性菌传播。
Clin Microbiol Infect. 2014 Jan;20 Suppl 1:1-55. doi: 10.1111/1469-0691.12427.
6
Effect of metallo-β-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study.金属β-内酰胺酶产生及多重耐药对铜绿假单胞菌血流感染患者临床结局的影响:一项回顾性队列研究
BMC Infect Dis. 2013 Nov 1;13:515. doi: 10.1186/1471-2334-13-515.
7
Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study.广泛耐药 VIM-2 阳性 ST235 铜绿假单胞菌在白俄罗斯、哈萨克斯坦和俄罗斯的传播:一项纵向流行病学和临床研究。
Lancet Infect Dis. 2013 Oct;13(10):867-76. doi: 10.1016/S1473-3099(13)70168-3. Epub 2013 Jul 9.
8
Time series analysis as a tool to predict the impact of antimicrobial restriction in antibiotic stewardship programs using the example of multidrug-resistant Pseudomonas aeruginosa.时间序列分析作为一种工具,用于预测抗生素管理计划中抗菌药物限制的影响,以多药耐药铜绿假单胞菌为例。
Antimicrob Agents Chemother. 2013 Apr;57(4):1797-803. doi: 10.1128/AAC.02142-12. Epub 2013 Feb 4.
9
Risk factors for extreme-drug resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies.血液恶性肿瘤患者中极耐药铜绿假单胞菌感染的危险因素。
Am J Infect Control. 2013 Feb;41(2):140-4. doi: 10.1016/j.ajic.2012.02.025. Epub 2012 Jul 15.
10
Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.广泛耐药铜绿假单胞菌:住院患者发生血流感染的风险。
Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2791-7. doi: 10.1007/s10096-012-1629-3. Epub 2012 May 4.